Drug intelligence / Profile preview

Relaxcol

Development stage: Unknown
Lead developer: Laboratoires Leurquin Mediolanum
Modality: Small Molecules
Administration: Oral

Overview

Relaxcol is a multi-ingredient dietary supplement developed by Laboratoires Leurquin-Mediolanum for the management of intestinal bloating, flatulence, and digestive discomfort. It is formulated as an oral capsule containing a blend of carminative plant extracts, including fennel, green anise, caraway, cinnamon, and coriander, alongside carob seed flour and fructo-oligosaccharides (FOS). The supplement works through a combination of mechanisms: the plant extracts provide carminative and antispasmodic effects to relax intestinal muscles, carob seed flour acts as an adsorbent to reduce gas, and FOS serves as a prebiotic to support intestinal transit. It is primarily marketed in pharmacies in France.

Brand names: Relaxcol

Beyond the preview

Go deeper on Relaxcol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Relaxcol.

Explore the full profile